Incannex Healthcare Inc.
Qualité des données : 100%
IXHL
NASDAQ
Manufacturing
Chemicals
3,53 €
▼
0,10 €
(-2,75%)
6 months return
—
Momentum
Neutral
ROE
-38,17%
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-38,17%
Au-dessus de la moyenne du secteur (-54,68%)
ROIC-28,25%
Net Margin-29288,78%
Op. Margin-27467,35%
Sécurité
Debt / Equity
N/A
Current Ratio48,27
Interest CoverageN/A
Valorisation
PE (TTM|NTM|2027)
-1,39 | 2,88 | 2,26
Au-dessus de la moyenne du secteur (-1,50)
P/B Ratio0,54
EV/EBITDAN/A
Dividend YieldN/A
Quick Summary
Key Takeaways
Short bullets derived from reported financials—not the AI summary above.
Negative free cash flow of -20,34 M
Capital intensive — 268,37% of revenue goes to capex
Price History
Tendances Financières
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Surprises de Résultats
EPS
Reported
Estimate
Forecast
Next: Q1 2026
·
EPS Est: -0,84 €
·
Rev Est: 0,0
| 2026-Q1 | 2026-Q2 | Q12025 | Q22025 | Q32025 | Q42025 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|
| Reported | -0,02 € | -0,02 € | -9,38 € | -23,26 € | -0,92 € | -0,85 € | — | — |
| Estimate | -0,84 € | -0,84 € | -21,72 € | -13,47 € | -18,09 € | -0,93 € | -0,84 € | -0,84 € |
| Surprise | +97,62% | +97,62% | +56,80% | -72,68% | +94,94% | +8,71% | — | — |
Growth
Rev 5Y: N/A · Earnings 1Y: N/A
Growth
Rev 5Y: N/A · Earnings 1Y: N/A| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
Profitability
ROE: -38,17% · Net Margin: -29288,78%
Profitability
ROE: -38,17% · Net Margin: -29288,78%| Revenue (TTM) | 98 000,0 | Net Income (TTM) | -28,70 M |
| ROE | -38,17% | ROA | -37,34% |
| Gross Margin | N/A | Operating Margin | -27467,35% |
| Net Margin | -29288,78% | Free Cash Flow (TTM) | -20,34 M |
| ROIC | -28,25% | FCF Growth (3Y) | N/A |
Safety
D/E: N/A · Current: 48,27
Safety
D/E: N/A · Current: 48,27| Debt / Equity | N/A | Current Ratio | 48,27 |
| Interest Coverage | N/A | Asset Turnover | 0,00 |
| Working Capital | 73,13 M | Tangible Book Value | 73,41 M |
Dividends
Yield: N/A · Payout: N/A
Dividends
Yield: N/A · Payout: N/A| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
Valuation
P/E: -1,39 · EV/EBITDA: N/A
Valuation
P/E: -1,39 · EV/EBITDA: N/A| P/E Ratio | -1,39 | Forward P/E | 2,88 |
| P/B Ratio | 0,54 | P/S Ratio | 406,38 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 0,70 | Fwd Earnings Yield | 34,72% |
| FCF Yield | -51,08% | ||
| Market Cap | 39,82 M | Enterprise Value | -29,08 M |
Per Share
EPS: -0,89 · FCF/Share: -1,46
Per Share
EPS: -0,89 · FCF/Share: -1,46| EPS (Diluted TTM) | -0,89 | Revenue / Share | 0,01 |
| FCF / Share | -1,46 | OCF / Share | -1,47 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
Efficiency
FCF Conv: 70,87% · CapEx/Rev: 268,37%
Efficiency
FCF Conv: 70,87% · CapEx/Rev: 268,37%| CapEx / Revenue | 268,37% | FCF Conversion | 70,87% |
| SBC-Adj. FCF | -27,78 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2024 | FY2025 | FY2022 |
|---|---|---|---|
| Revenue | 12 000,0 | — | — |
| Net Income | -18,46 M | -46,89 M | — |
| EPS (Diluted) | -1,15 | -1,35 | — |
| Gross Profit | — | — | — |
| Operating Income | -30,04 M | -23,79 M | — |
| EBITDA | — | — | — |
| R&D Expenses | 12,88 M | 10,75 M | — |
| SG&A Expenses | — | — | — |
| D&A | 103 000,0 | 246 000,0 | — |
| Interest Expense | — | 303 000,0 | — |
| Income Tax | 30 000,0 | 30 000,0 | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2024 | FY2025 |
|---|---|---|
| Total Assets | 17,05 M | 20,45 M |
| Total Liabilities | 5,83 M | 7,06 M |
| Shareholders' Equity | 11,22 M | 13,39 M |
| Total Debt | — | — |
| Cash & Equivalents | 5,86 M | 15,04 M |
| Current Assets | 16,20 M | 19,96 M |
| Current Liabilities | 5,62 M | 6,98 M |
Comparaison Sectorielle
vs médiane du secteur Manufacturing (1605 pairs)
Par rapport à des entreprises similaires dans Manufacturing
Comparaison Sectorielle
vs médiane du secteur Manufacturing (1605 pairs) Par rapport à des entreprises similaires dans Manufacturing| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -1,4 | -1,5 |
| P/B | 0,5 | 1,6 |
| ROE % | -38,2 | -54,7 |
| Net Margin % | -29288,8 | -41,5 |
| Rev Growth 5Y % | — | 1,7 |
| D/E | — | 0,3 |
{"event":"ticker_viewed","properties":{"ticker":"IXHL","listing_kind":"stock","pathname":"/stocks/ixhl","exchange":"NASDAQ","country":"US"}}